Zacks Investment Management Biogen Inc. Transaction History

Zacks Investment Management

$8.87 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $220,841 - $258,728	-909 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $15,829 - $23,827	-67 Reduced 6.86%	909 $223,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $6.73 Million - $7.77 Million	-25,410 Reduced 96.3%	976 $277,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $4.88 Million - $6.47 Million	-18,880 Reduced 41.71%	26,386 $7.06 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $58,340 - $74,005	217 Added 0.48%	45,266 $14.3 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $89,124 - $123,148	-405 Reduced 0.89%	45,049 $13.4 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $13,263 - $14,876	61 Added 0.13%	45,454 $10.6 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $5,043 - $5,559	-23 Reduced 0.05%	45,393 $10.6 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $122,657 - $191,851	566 Added 1.26%	45,416 $10.7 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $352,859 - $446,934	-1,267 Reduced 2.75%	44,850 $13.5 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.44 Million - $3.19 Million	8,310 Added 21.98%	46,117 $16.3 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $15,966 - $19,028	-62 Reduced 0.16%	37,807 $11 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $60,350 - $85,355	232 Added 0.62%	37,869 $10.4 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $42,146 - $47,207	-137 Reduced 0.36%	37,637 $12 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $10.6 Million - $12.5 Million	37,774	37,774 $11.8 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Account